| Inhaled nitric oxide for the adult respiratory distress syndrome R Rossaint, KJ Falke, F Lopez, K Slama, U Pison, WM Zapol New England Journal of Medicine 328 (6), 399-405, 1993 | 2305 | 1993 |
| Nanomedicine for respiratory diseases U Pison, T Welte, M Giersig, DA Groneberg European journal of pharmacology 533 (1-3), 341-350, 2006 | 335 | 2006 |
| One-pot synthesis of PEGylated ultrasmall iron-oxide nanoparticles and their in vivo evaluation as magnetic resonance imaging contrast agents JF Lutz, S Stiller, A Hoth, L Kaufner, U Pison, R Cartier Biomacromolecules 7 (11), 3132-3138, 2006 | 322 | 2006 |
| Surfactant Abnormalities in Patients with Respiratory Failure after Multiple Trauma1-3 U Pison, W Seeger, R Buchhorn, T Joka, M Brand, U Obertacke, H Neuhof, ... Am Rev Respir Dis 140, 1033-1039, 1989 | 295 | 1989 |
| Polymorphisms of human SP‐A, SP‐B, and SP‐D genes: association of SP‐B Thr131Ile with ARDS Z Lin, C Pearson, V Chinchilli, SM Pietschmann, J Luo, U Pison, J Floros Clinical genetics 58 (3), 181-191, 2000 | 267 | 2000 |
| Maghemite nanoparticles protectively coated with poly (ethylene imine) and poly (ethylene oxide)-b lock-poly (glutamic acid) AF Thünemann, D Schütt, L Kaufner, U Pison, H Möhwald Langmuir 22 (5), 2351-2357, 2006 | 253 | 2006 |
| Interfacial properties of pulmonary surfactant layers R Wüstneck, J Perez-Gil, N Wüstneck, A Cruz, VB Fainerman, U Pison Advances in colloid and interface science 117 (1-3), 33-58, 2005 | 240 | 2005 |
| Pulmonary surfactant: functions, abnormalities and therapeutic options I Frerking, A Günther, W Seeger, U Pison Intensive care medicine 27, 1699-1717, 2001 | 233 | 2001 |
| Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange U Pison, FA Lopez, CF Heidelmeyer, R Rossaint, KJ Falke Journal of Applied Physiology 74 (3), 1287-1292, 1993 | 209 | 1993 |
| Nanoparticle-based diagnosis and therapy DA Groneberg, M Giersig, T Welte, U Pison Current drug targets 7 (6), 643-648, 2006 | 208 | 2006 |
| Host defence capacities of pulmonary surfactant: evidence for ‘non‐surfactant’functions of the surfactant system U Pison, M Max, A Neuendank, S Weissbach, S Pietschmann European journal of clinical investigation 24 (9), 586-599, 1994 | 200 | 1994 |
| Specific binding of surfactant apoprotein SP-A to rat alveolar macrophages U Pison, JR Wright, S Hawgood American Journal of Physiology-Lung Cellular and Molecular Physiology 262 (4 …, 1992 | 147 | 1992 |
| Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase U Pison, EK Tam, GH Caughey, S Hawgood Biochimica et Biophysica Acta (BBA)-General Subjects 992 (3), 251-257, 1989 | 127 | 1989 |
| Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure U PISON, UDO Obertacke, M BRAND, W SEEGER, T JOKA, J BRUCH, ... Journal of Trauma and Acute Care Surgery 30 (1), 19-26, 1990 | 100 | 1990 |
| DCL-HB for trauma patients with severe hemorrhagic shock: the European" on-scene" multicenter study T Kerner, O Ahlers, S Veit, B Riou, M Saunders, U Pison, ... Intensive care medicine 29, 378-385, 2003 | 95 | 2003 |
| Quantitative analysis of pulmonary surfactant phospholipids by high-performance liquid chromatography and light-scattering detection H Bünger, U Pison Journal of Chromatography B: Biomedical Sciences and Applications 672 (1), 25-31, 1995 | 94 | 1995 |
| Surfactant protein A modulates release of reactive oxygen species from alveolar macrophages S Weissbach, A Neuendank, M Pettersson, T Schaberg, U Pison American Journal of Physiology-Lung Cellular and Molecular Physiology 267 (6 …, 1994 | 91 | 1994 |
| Surfactant protein A (SP‐A) is decreased in acute parenchymal lung injury associated with polytrauma U Pison, U Obertacke, W Seeger, S Hawgood European journal of clinical investigation 22 (11), 712-718, 1992 | 87 | 1992 |
| Kinetics of adsorption of globular proteins at liquid/fluid interfaces R Miller, EV Aksenenko, VB Fainerman, U Pison Colloids and Surfaces A: Physicochemical and Engineering Aspects 183, 381-390, 2001 | 86 | 2001 |
| Inhaled nitric oxide selectively reduces pulmonary hypertension in severe ARDS and improves gas exchange as well as right heart ejection fraction. A case report K Falke Am Rev Resp Dis 143, A248, 1991 | 81 | 1991 |
